Oxidative stress as a therapeutic perspective for ATM-deficient chronic lymphocytic leukemia patients

Haematologica. 2015 Aug;100(8):994-6. doi: 10.3324/haematol.2015.130260.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ataxia Telangiectasia Mutated Proteins / deficiency*
  • Ataxia Telangiectasia Mutated Proteins / genetics
  • Ataxia Telangiectasia Mutated Proteins / metabolism
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / metabolism
  • Epistasis, Genetic
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / metabolism*
  • Molecular Targeted Therapy
  • Oxidative Stress* / drug effects

Substances

  • Ataxia Telangiectasia Mutated Proteins